Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

0.94
Delayed Data
As of 3:59pm ET
 +0.02 / +2.17%
Today’s Change
0.82
Today|||52-Week Range
2.90
-25.40%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues134.0K134.0K15.2M3.6M
 
 
 
 
 
Depreciation And Amortization4.5M--97.0K6.0K
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses1.5M4.7M6.6M9.7M
 
 
 
 
 
Research And Development451.0K--4.4M3.9M
 
 
 
 
Total Operating Expenses6.0M4.7M6.7M9.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.8M-4.6M8.5M-6.1M
 
 
 
 
 
Extraordinary Charge-4.3M-25.0K----
 
 
 
Interest Expense On Debt716.0K633.0K533.0K425.0K
 
 
 
 
 
Other Expenses-14.0K-209.0K-22.0K-44.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.9M-5.5M7.9M-6.6M
 
 
 
 
 
Net Income-10.9M-5.5M7.9M-6.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS52.6M55.2M56.8M58.1M
 
 
 
 
 
Shares To Calculate EPS Diluted52.6M55.2M57.0M58.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.21-$0.10$0.14-$0.11
 
 
 
 
 
EPS Diluted-$0.21-$0.10$0.14-$0.11